If your Paragard copper IUD broke during removal and you needed a procedure to retrieve the fragments, here is who may qualify in MDL 2974 — and where the litigation stands after the first bellwether trial ended in a defense verdict.
This page describes ongoing litigation and an investigation. The statements below are unproven allegations. The manufacturers have not been found liable — the first jury to hear these claims returned a defense verdict — no settlement has been finalized, and eligibility depends on the facts of each case. This page is informational and is not legal or medical advice. Do not remove or alter any medical device without consulting your doctor.
Plaintiffs allege that the Paragard copper (hormone-free) IUD can break or fracture during removal, leaving copper fragments embedded in the uterus or migrating in the body — allegedly requiring surgical procedures such as hysteroscopy, laparoscopy, or in some alleged cases hysterectomy to retrieve them. The claims are failure to warn and defective design. These allegations are unproven.
Paragard is a copper T 380A intrauterine device. It was originally developed and marketed by Teva Pharmaceuticals. In 2017, CooperSurgical, a subsidiary of The Cooper Companies, acquired Paragard and is the current manufacturer. Teva, CooperSurgical, and Cooper Companies entities are named as defendants in the litigation.
The claims generally involve people who had a Paragard IUD that broke or fractured on removal, leaving a retained fragment and requiring a corrective procedure to remove it. Alleged injuries include organ perforation, infection, scarring, and loss of fertility. Eligibility depends on the facts of each case.
No. As of mid-2026 there is no global settlement. The first bellwether trial ended in a defense verdict for Teva in February 2026, and the court postponed the remaining bellwether trials to later in 2026. There is no settlement fund and no claim form at this time.
Free settlement alerts
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.